Gene Query: PPP1CB

Dataset Description Geneva Score
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 65.65
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 55.19
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 48.32
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 40.96
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 40.96
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 35.76
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 35.16
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 33.53
Triple vectors expand AAV transfer capacity in the retina 32.44
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 31.67
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 30.89
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 30.89
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 30.87
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 30.69
CD73 knockdown effect in pancreatic cancer cell lines 30.14
Human cell line and subcutaneous tumor 30.11
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 29.28
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 29.28
Co-transcriptional loading of RNA export factors shapes the human transcriptome 28.69
RNAseq of HEK293 cells after Chtop knockdown 28.69
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 28.01
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 27.82
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 27.46
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 26.22
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 26.2
RIG-I and MDA5 fRIP during KSHV lytic reactivation 26.08
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 25.72
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 24.54
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 23.69
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 22.79
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 22.62
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 22.24
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 21.85
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 21.49
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 21.49
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 21.32
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 21.28
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 20.97
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 19.95
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 19.14
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 19.1
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 19.08
Characterization of the Merkel cell carcinoma miRNome 18.32
Transcriptomic analysis of the HOTAIR-regulated genes 18.31
Altering cancer transcriptomes using epigenomic inhibitors 18.28
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 18.28
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 17.87
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 17.87
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 17.85
METTL3 promotes translation in human cancer cells 17.7
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 16.98
High-throughput sequencing of PROMPT-enriched samples. 16.96
IL-33 activates tumor stroma to promote intestinal polyposis 16.89
RNA-Seq of PRMT1 overexpression ECA109 cells 16.31
TT-Seq captures the human transient transcriptome 16.21
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 16.21
RNA-Seq with and without RNase treatment in PCa cell lines 15.86
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 15.8
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 15.64
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 15.52
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 15.32
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 15.32
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.14
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 15.01
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.96
Role of microRNAs in the interaction between Salmonella and the host cell 14.73
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.72
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 14.52
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 14.17
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 14.17
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 14.08
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 14.06
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 13.99
Next generation sequencing of small RNAs isolated from exosomes in human semen 13.98
3’ Uridylation Expands miRNA Target Repertoire 13.83
mRNA expression in human DAOY cells 13.83
RNA transcriptome analysis during HSV-1 infection 13.79
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 13.7
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 13.69
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.47
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 13.39
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 13.33
Human cells contain natural double-stranded RNAs with potential regulatory capacity 13.17
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 13.16
The transcriptome effect of overexpressing EZH2 in MCF7 13.03
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.95
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 12.89
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 12.88
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 12.87
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 12.6
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.48
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 12.42
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 12.36
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 12.35
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 12.26
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 12.06
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 12.01
Comparative Analysis of Cas9 Activators Across Multiple Species 11.98
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 11.8
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 11.79
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 11.78
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 11.78
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 11.71
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 11.65
Hepatocyte maturation 11.49
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 11.4
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 11.36
NRDE2 negatively regulates nuclear exosome functions 11.28
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 11.28
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 11.19
Interaction between mitoNEET and NAF-1 in cancer cells 11.11
RNA-seq of naive and primed ES cells 11.07
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 10.96
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 10.96
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 10.91
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 10.83
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 10.83
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.8
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 10.78
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 10.76
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 10.66
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 10.66
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.63
Sensing self and nonself circular RNAs 10.58
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 10.48
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 10.37
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 10.36
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.27
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 10.22
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 10.2
Survival of pancreatic cancer cells lacking KRAS function 10.16
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 10.14
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.14
CROP-Seq in Primary Human T Cells 10.08
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 10.02
Identification of renal resident macrophages across species [C1] 9.9
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 9.84
K562 polyA RNA-Seq 9.8
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 9.79
Genome-wide discovery of human splicing branchpoints [RNAse] 9.77
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 9.7
RNA-seq melanoma 9.65
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 9.6
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 9.6
Cleavage Factor Im as a key regulator of 3’ UTR length 9.6
Determination of tRNA aminoacylation levels by high throughput sequencing 9.59
Human neutrophil genome during PMA- and E. coli encounter-induced activation 9.56
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 9.56
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.42
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 9.4
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.38
Global Mapping of Human RNA-RNA Interactions 9.31
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.3
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 9.22
Differential gene expression of human melanoma cells [RNA-seq] 9.21
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 9.21
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 9.18
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 9.18
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 9.16
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 9.11
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 9.09
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 9.01
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.98
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 8.96
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.84
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.82
The human blood-nerve barrier transcriptome 8.81
mRNA expression profile of Lymphocytes 8.77
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.73
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.73
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 8.71
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 8.71
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 8.71
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 8.71
SLAM-seq for K562 endogenous mRNA decay 8.68
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.67
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.67
The comparison of high-throughput single-cell RNA-seq methods 8.66
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.61
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.49
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.49
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 8.46
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.46
Genes significantly down or Up-regulated upon RNF219 knockdown 8.38
Gene expression profiling of leukemia cells following asparagine depletion 8.3
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.29
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.27
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.2
RNA-seq of RKO cells with cTAZ KO or putback 8.18
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.12
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 8.05
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 8.01
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 8.0
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 8.0
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 7.94
CD95/Fas ligand mRNA is toxic to cells 7.79
An optimization system for isolating and sequencing of single human colon cancer cells 7.79
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 7.74
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 7.72
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 7.72
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 7.7
Exploring the RNA landscape of endothelial exosomes 7.7
Expression data from miR340 overexpressing human A549 cells 7.59
Generation and persistence of human tissue-resident memory T cells in lung transplantation 7.59
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.54
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 7.51
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 7.5
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 7.43
Solid phase chemistry to covalently and reversibly capture thiolated RNA 7.35
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 7.35
Global analysis of enhancer targets: Mosaic-seq 7.32
Differetially expressed genes after hTR overexpression in U2OS cells 7.3
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 7.3
Molecular Criteria for Defining the Naive Human Pluripotent State 7.26
Downregulation of LATS kinases alters p53 to promote cell migration 7.25
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 7.22
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 7.22
Chromatin-informed inference of transcriptional programs in gynecologic cancers 7.18
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 7.18
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 7.14
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 7.14
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 7.14
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 7.12
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 7.12
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 7.11
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 7.09
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 7.03
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.99
Mapping interactions for the TNIP2 hub protein 6.97
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.81
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.79
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.77
The contribution of Alu exons to the human proteome 6.71
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 6.64
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 6.58
Effect of PRDM11 depletion in U2932 cells 6.55
X-Ray induced DNA-Hydroxymethylation changes 6.53
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 6.53
Reassessment of Exosome Composition 6.52
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.49
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 6.49
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 6.37
scRNASeq analysis of cycling cardiomyocytes 6.35
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.32
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.32
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 6.29
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 6.28
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.24
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.22
RNA-seq of IL-4 stimulated human keratinocytes 6.22
KLF6-dependent transcription in renal cancer cells 6.15
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.09
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 5.99
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 5.97
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.97
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.94
RNAseq in Alzheimer's Disease patients 5.84
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.82
Proteomics identifies a marker signature of MAPKi resistance in melanoma 5.79
Regulatory network controlling tumor-promoting inflammation in human cancers 5.74
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.74
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 5.73
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.72
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.72
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 5.63
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 5.59
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 5.59
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 5.55
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 5.55
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 5.53
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 5.34
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 5.27
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 5.26
Measure transcript integrity using RNA-seq data 5.18
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.18
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.01
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 5.01
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 4.92
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.92
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.92
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.89
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 4.89
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.89
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.87
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 4.87
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.85
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.84
Transcriptome analysis of kidney organoids 4.82
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 4.74
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 4.73
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 4.73
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.7
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.69
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 4.69
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.68
The transcriptome and chromatin accessbility landscape of mammalian germline 4.67
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 4.66
Transcriptomes of oxLDL exposed trained monocytes 4.66
oxLDL exposed trained monocytes 4.66
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.64
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 4.62
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.58
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 4.55
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.54
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 4.53
Transcriptomic profiling of human peripheral blood-derived mast cells 4.53
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 4.47
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 4.47
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 4.42
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 4.42
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 4.41
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 4.3
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 4.28
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 4.28
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.27
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.19
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 4.19
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 4.19
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 4.14
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.14
Alteration of the microRNA network during the progression of Alzheimer’s disease 4.12
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.06
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.98
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.95
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 3.92
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.9
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.85
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.76
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 3.75
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.72
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.57
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.57
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.55
Transcriptome analysis of CNS leukemia 3.55
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 3.53
Identification of renal resident macrophages across species 3.48
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 3.45
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 3.44
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 3.44
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 3.4
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.38
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.34
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 3.3
SRSF1 role in cellular gene expression and splicing 3.3
Mitochondrial dsRNA triggers antiviral signalling in humans 3.28
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.26
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 3.23
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 3.18
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.13
Transcriptome analysis of peripheral blood monocytes 3.11
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 3.04
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.03
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 3.03
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.03
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.02
Argonaute proteins couple chromatin silencing to alternative splicing 3.02
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 3.02
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.93
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.82
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.8
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.77
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 2.75
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.73
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 2.72
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.7
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.64
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.63
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.6
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 2.59
CDK12 mediated transcriptional regulation in U2OS cells 2.58
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.56
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.55
Role of cervicovaginal microbiota in genital inflammation 2.51
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.49
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.46
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.43
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.43
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.43
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.43
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.36
Preclinical model of obesity and ER-positive breast cancer 2.34
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.31
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.3
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.24
Transcriptome-wide response to synthetic chromatin protein PcTF 2.23
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.2
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.2
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.2
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.19
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.13
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.11
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.1
BCL11B 2.09
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.09
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.05
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 2.04
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 2.04
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.01
Gene expression profiling in metabolically heterogeneous human lung tumors 2.0
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.96
Metastasis in triple-negative breast cancer 1.95
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.95
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.94
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.93
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.92
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.9
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.9
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.9
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.86
naive T cell heterogeneity after neonatal thymectomy 1.84
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.75
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.74
Targeted enhancer activation by a subunit of the integrator complex 1.73
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.73
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.71
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.7
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.68
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.68
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.58
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.58
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.57
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.57
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.49
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 1.47
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.42
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.29
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.25
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.25
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 1.25
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 1.21
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 1.2
Exogenous rescue of KLHL9 in SF210 cell line 1.18
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.17
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.15
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.12
Transcription elongation regulates genome 3D structure 1.08
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.07
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.03
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 1.03
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.01
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.99
Differential gene expression profiles in imatinib-resistant cell lines 0.99
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.95
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.95
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.94
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.93
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.93
mRNA recovered upon RNF219 IP. [RNA-IP] 0.9
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.89
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.89
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.87
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.87
Evaluating pre-clinical models for studying NASH driven HCC. 0.85
Dilated cardiomyopathy vs Myocarditis 0.83
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.82
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.81
BACH2 in human plasma cell fate decision 0.78
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.78
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.71
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.69
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.68
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.67
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.66
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.64
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.64
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 0.61
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.61
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.57
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.53
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.52
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.52
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.52
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.5
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.48
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.47
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.44
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.43
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.43
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.37
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.36
Iron response of HepG2 cells 0.35
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.32
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.32
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.32
High-resolution comparative analysis of great ape genomes 0.3
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.29
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.28
Modulation of nonsense-mediated decay by rapamycin 0.22
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.22
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.22
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.2
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.14
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.12
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.09
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.07
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation